Effects of a Three-week Inpatient Pulmonary Rehabilitation Program on Walking Speed in Patients With Chronic Obstructive Pulmonary Disease (COPD) or Interstitial Lung Diseases (ILD)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Sponsor
- Schön Klinik Berchtesgadener Land
- Enrollment
- 43
- Locations
- 1
- Primary Endpoint
- change of maximum walking speed
- Last Updated
- 6 years ago
Overview
Brief Summary
The aim of this study is to evaluate the effects of a three-week inpatient pulmonary rehabilitation (PR) program on the walking speed in patients with chronic obstructive (COPD) or interstitial lung disease (ILD).
Detailed Description
At most german traffic light crossings, a walking speed of 1,2m/sec is required to cross the road in time. Patients who are unable to cross the road at this speed, expose themselves to an increased level of stress and possibly the risk of accidents. Thus, they are discouraged from participating in an active social life. An UK study (Nolan et al., Thorax 2018) showed that only 10.7% of the 926 patients with moderate COPD attained a walking speed of 1.2m/sec. As PR plays a key role in the management of chronic lung diseases in order to improve patients´ exercise capacity, the aim of this study was to evaluate the PR effects on the Walking Speed in patients with COPD or ILD. The investigators hypothesize that PR improves the ability to cross the road in the appropriate time.
Investigators
Klaus Kenn
Prof. Dr. Klaus Kenn
Schön Klinik Berchtesgadener Land
Eligibility Criteria
Inclusion Criteria
- •Participation in a pulmonary Rehabilitation program (Schön Klinik BGL)
- •Indication: COPD or ILD
- •COPD; FEV1 \<50%
- •ILD: FVC \<70%
- •written informed consent
Exclusion Criteria
- •non compliance
Outcomes
Primary Outcomes
change of maximum walking speed
Time Frame: Day 1 and Day 21
assessed during a walk of 11m
Secondary Outcomes
- Change in tension symptoms during a field walk test(Day 1 and Day 21)
- Change in walking speed during a field walk test(Day 1 and Day 21)
- Change in Quality of life: Chronic Respiratory Disease Questionnaire (CRQ)(Day 1 and Day 21)
- Change of usual walking Speed(Day 1 and Day 21)
- Change in balance(Day 1 and Day 21)
- Change in maximum leg strength(Day 1 and Day 21)
- Change in illness perception(Day 1 and Day 21)
- Change of exercise capacity(Day 1 and Day 21)
- Change of frailty (FFP)(Day 1 and Day 21)
- Change in anxiety and Depression symptoms(Day 1 and Day 21)
- Change in COPD-related fears on disease-specific disability(Day 1 and Day 21)